In contrast, class I HLA-lacking B2M knockout (B2M−/−DRB1−/−) ECs and HLA-devoid K562 tumor cells were significantly vulnerable to NK cell cytotoxicity (Fig. 3c). Here, B2M is linked to neoplasm.